Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Apr;80(1-2):110–116. doi: 10.1038/sj.bjc.6690329

Anti-tumour promoter activity in Malaysian ginger rhizobia used in traditional medicine

S Vimala 1, A W Norhanom 2, M Yadav 3
PMCID: PMC2362999  PMID: 10389986

Abstract

Zingiberaceae rhizomes commonly used in the Malaysian traditional medicine were screened for anti-tumour promoter activity using the short-term assay of inhibition of 12-O-tetradecanoyl phorbol-13-acetate (TPA)-induced Epstein-Barr virus early antigen (EBV-EA) in Raji cells. The inhibition of TPA-induced EBV-EA was detected using the indirect immunofluorescence assay (IFA) and Western blot technique. The indirect IFA detected the expression/inhibition of EBV-EA-D (diffused EA antigen), whereas the Western blot technique detected the expression/inhibition of both EBV-EA-D and EA-R (restricted EA antigen). Seven rhizomes were found to possess inhibitory activity towards EBV activation, induced by TPA; they are: Curcuma domestica, C. xanthorrhiza, Kaempferia galanga, Zingiber cassumunar, Z. officinale, Z. officinale (red variety), and Z. zerumbet. A cytotoxicity assay was carried out to determine the toxicity of the Zingiberaceae rhizome extracts. The rhizome extracts that exhibited EBV activation inhibitory activity had no cytotoxicity effect in Raji cells. Therefore, the present study shows that several Zingiberaceae species used in Malaysian traditional medicine contain naturally occurring non-toxic compounds that inhibit the EBV activation, which, if further investigated, could contribute in the development of cancer prevention methods at the tumour-promoting stage. © 1999 Cancer Research Campaign

Keywords: anti-tumour promoters, Zingiberaceae, EBV-EA inhibition

Full Text

The Full Text of this article is available as a PDF (109.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boutwell R. K. Model systems for defining initiation, promotion, and progression of skin neoplasms. Prog Clin Biol Res. 1989;298:3–15. [PubMed] [Google Scholar]
  2. Burnette W. N. "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem. 1981 Apr;112(2):195–203. doi: 10.1016/0003-2697(81)90281-5. [DOI] [PubMed] [Google Scholar]
  3. Greenwald P., Nixon D. W., Malone W. F., Kelloff G. J., Stern H. R., Witkin K. M. Concepts in cancer chemoprevention research. Cancer. 1990 Apr 1;65(7):1483–1490. doi: 10.1002/1097-0142(19900401)65:7<1483::aid-cncr2820650706>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  4. Henle G., Henle W. Immunofluorescence in cells derived from Burkitt's lymphoma. J Bacteriol. 1966 Mar;91(3):1248–1256. doi: 10.1128/jb.91.3.1248-1256.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Henle G., Henle W., Klein G. Demonstration of two distinct components in the early antigen complex of Epstein-Barr virus-infected cells. Int J Cancer. 1971 Sep 15;8(2):272–282. doi: 10.1002/ijc.2910080212. [DOI] [PubMed] [Google Scholar]
  6. Hennings H., Shores R., Wenk M. L., Spangler E. F., Tarone R., Yuspa S. H. Malignant conversion of mouse skin tumours is increased by tumour initiators and unaffected by tumour promoters. Nature. 1983 Jul 7;304(5921):67–69. doi: 10.1038/304067a0. [DOI] [PubMed] [Google Scholar]
  7. Ito Y., Kawanishi M., Harayama T., Takabayashi S. Combined effect of the extracts from Croton tiglium, Euphorbia lathyris or Euphorbia tirucalli and n-butyrate on Epstein-Barr virus expression in human lymphoblastoid P3HR-1 and Raji cells. Cancer Lett. 1981 Apr;12(3):175–180. doi: 10.1016/0304-3835(81)90066-5. [DOI] [PubMed] [Google Scholar]
  8. Ito Y., Yanase S., Fujita J., Harayama T., Takashima M., Imanaka H. A short-term in vitro assay for promoter substances using human lymphoblastoid cells latently infected with Epstein-Barr virus. Cancer Lett. 1981 Jun;13(1):29–37. doi: 10.1016/0304-3835(81)90083-5. [DOI] [PubMed] [Google Scholar]
  9. Ito Y., Yanase S., Tokuda H., Kishishita M., Ohigashi H., Hirota M., Koshimizu K. Epstein-Barr virus activation by tung oil, extracts of Aleurites fordii and its diterpene ester 12-O-hexadecanoyl-16-hydroxyphorbol-13-acetate. Cancer Lett. 1983 Feb;18(1):87–95. doi: 10.1016/0304-3835(83)90121-0. [DOI] [PubMed] [Google Scholar]
  10. Kawanishi M., Ito Y. Similarity of Epstein-Barr virus early polypeptides induced by various tumor promoters. Cancer Lett. 1982 May-Jun;16(1):19–23. doi: 10.1016/0304-3835(82)90086-6. [DOI] [PubMed] [Google Scholar]
  11. Konoshima T., Kokumai M., Kozuka M., Iinuma M., Mizuno M., Tanaka T., Tokuda H., Nishino H., Iwashima A. Studies on inhibitors of skin tumor promotion. XI. Inhibitory effects of flavonoids from Scutellaria baicalensis on Epstein-Barr virus activation and their anti-tumor-promoting activities. Chem Pharm Bull (Tokyo) 1992 Feb;40(2):531–533. doi: 10.1248/cpb.40.531. [DOI] [PubMed] [Google Scholar]
  12. Koshimizu K., Ohigashi H., Tokuda H., Kondo A., Yamaguchi K. Screening of edible plants against possible anti-tumor promoting activity. Cancer Lett. 1988 Apr;39(3):247–257. doi: 10.1016/0304-3835(88)90067-5. [DOI] [PubMed] [Google Scholar]
  13. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  14. Morse M. A., Stoner G. D. Cancer chemoprevention: principles and prospects. Carcinogenesis. 1993 Sep;14(9):1737–1746. doi: 10.1093/carcin/14.9.1737. [DOI] [PubMed] [Google Scholar]
  15. Murakami A., Jiwajinda S., Koshimizu K., Ohigashi H. Screening for in vitro anti-tumor promoting activities of edible plants from Thailand. Cancer Lett. 1995 Aug 16;95(1-2):139–146. doi: 10.1016/0304-3835(95)03879-2. [DOI] [PubMed] [Google Scholar]
  16. Murakami A., Ohigashi H., Koshimizu K. Anti-tumor promotion with food phytochemicals: a strategy for cancer chemoprevention. Biosci Biotechnol Biochem. 1996 Jan;60(1):1–8. doi: 10.1271/bbb.60.1. [DOI] [PubMed] [Google Scholar]
  17. Ohigashi H., Sakai Y., Yamaguchi K., Umezaki I., Koshimizu K. Possible anti-tumor promoting properties of marine algae and in vivo activity of Wakame seaweed extract. Biosci Biotechnol Biochem. 1992 Jun;56(6):994–995. doi: 10.1271/bbb.56.994. [DOI] [PubMed] [Google Scholar]
  18. Ohigashi H., Takamura H., Koshimizu K., Tokuda H., Ito Y. Search for possible antitumor promoters by inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced Epstein-Barr virus activation; ursolic acid and oleanolic acid from an anti-inflammatory Chinese medicinal plant, Glechoma hederaceae L. Cancer Lett. 1986 Feb;30(2):143–151. doi: 10.1016/0304-3835(86)90082-0. [DOI] [PubMed] [Google Scholar]
  19. Pitot H. C., Dragan Y. P. Facts and theories concerning the mechanisms of carcinogenesis. FASEB J. 1991 Jun;5(9):2280–2286. [PubMed] [Google Scholar]
  20. Pitot H. C., Sirica A. E. The stages of initiation and promotion in hepatocarcinogenesis. Biochim Biophys Acta. 1980 May 6;605(2):191–215. doi: 10.1016/0304-419x(80)90004-9. [DOI] [PubMed] [Google Scholar]
  21. Rogers A. E., Zeisel S. H., Groopman J. Diet and carcinogenesis. Carcinogenesis. 1993 Nov;14(11):2205–2217. doi: 10.1093/carcin/14.11.2205. [DOI] [PubMed] [Google Scholar]
  22. Tokuda H., Ohigashi H., Koshimizu K., Ito Y. Inhibitory effects of ursolic and oleanolic acid on skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Cancer Lett. 1986 Dec;33(3):279–285. doi: 10.1016/0304-3835(86)90067-4. [DOI] [PubMed] [Google Scholar]
  23. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Wattenberg L. W. Chemoprevention of cancer. Cancer Res. 1985 Jan;45(1):1–8. [PubMed] [Google Scholar]
  25. zur Hausen H., Bornkamm G. W., Schmidt R., Hecker E. Tumor initiators and promoters in the induction of Epstein-Barr virus. Proc Natl Acad Sci U S A. 1979 Feb;76(2):782–785. doi: 10.1073/pnas.76.2.782. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. zur Hausen H., O'Neill F. J., Freese U. K., Hecker E. Persisting oncogenic herpesvirus induced by the tumour promotor TPA. Nature. 1978 Mar 23;272(5651):373–375. doi: 10.1038/272373a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES